Saturday, March 3, 2012

Research: EFFECTS OF COBALT

Symptoms of cobaltism include irritability, fatigue, tinnitus, hearing loss, headaches, loss of coordination, cognitive decline, and depression.

Arthroprosthetic Cobaltism : Neurological & Cardiac Manifestations - The Journal of Bone & Joint Surgery
Oct 29,2010



International Agency for Research on Cancer
The IARC has determined that cobalt is possibly carcinogenic to humans.

The Journal of Bone & Joint Surgery, Volume 92, Issue 17
Many patients with metal-on-metal hip implants may develop renal impairment with time. Neurological and cardiac assessments should be considered for patients with a serum cobalt level of =7 µg/L. Revision arthroplasty should be considered for patients with periprosthetic metallosis and those with neurological or cardiac impairments temporally linked to elevated serum cobalt levels. Surgeons need to be aware that the high serum cobalt levels found in some patients with metal-on-metal hips may cause neurological or cardiac damage that is in part reversible with timely revision surgery.

US National Library of Medicine, National Institutes of Health
MoM hip bearings are being scrutinized due to high early failure rates and concerns that the results of the revision surgeries will be poor. However, orthopedic surgeons and the general medical community are unaware that patients with MoM bearings are also at risk for cobaltism. Medical providers need to know that hip arthroplasty implantees that present with symptom complexes that include tinnitus, deafness, vertigo, visual changes, rashes, hypothyroidism, tremor, dyspnea on exertion, mood disorders, dementia, heart failure, and peripheral neuropathy may be presenting arthroprosthetic cobaltism. These patients need to be asked if they have had a hip replacement and if so what type. For those patients implanted with a MoM bearing or those with a history of hip revision for a failed ceramic bearing obtaining a [Co] is indicated. MoM implantees with renal failure are a particularly high risk for cobaltism. Patients with a cobalt levels of greater than 7 mcg/l bear observation of neurologic and cardiac function. Those patients with levels greater than 20 should be advised to have revision of their hip arthroplasty to a bearing that eliminates cobalt. Most patients implanted with MoM bearing have cobalt levels greater than those allowed in industry and cobalt exposed workers may have an increased incidence of subclinical cognitive and cardiac impairments.

Department of Orthopaedics, Rheumatology and Musculoskeletal Surgery, University of Oxford
Theoretical, desirable features of second-generation metal-on-metal (MoM) hip prostheses have led to their widespread use. However, the bearing surfaces, consisting of complex cobalt-chromium alloys, are subject to wear and the release of cobalt and chromium (CoCr) nanoparticles. These nanoparticles can reduce cellular viability, induce DNA damage, lead to chromosomal aberrations, and possibly stimulate increased metal hypersensitivity. Clinically, the effects can be both local (soft-tissue reactions) and systemic (arthroprosthetic cobaltism). This review assesses the literature concerning the in vitro and in vivo cytotoxic, genotoxic, and immunotoxic effects of CoCr wear particles, which is increasingly important in view of the large number of MoM arthroplasties performed.

The Journal of Bone and Joint Surgery (American) 0:JBJS.J.00125-jbjs.J00125 (2010)
A serum cobalt level of >7 µg/L indicates possible periprosthetic metallosis. A normal serum cobalt level is 0.19 µg/L, and 95% of those who are unexposed to cobalt have a value of <0.41 µg/L.
A serum cobalt level of >1 µg/L indicates excessive cobalt exposure, and levels of >5 µg/L are considered toxic. Patients may become high risk for cobaltism if renal function declines and those in which ASR implants are used. [Mine is 16.9 ug/L]

A recent letter to the BMJ (Arthroprosthetic cobaltism associated with metal on metal implants. BMJ 2012;344:e430) describes several patients who received the metal-on-metal hip implants who developed progressive hip pain, elevated cobalt levels, cognitive impairment, neuropathy, and cardiomyopathy. Associated symptoms included new onset depression, anxiety, tinnitus, and thyroid abnormalities.

Effects of Cobalt Nanoparticles on Human T Cells
Department of Orthopedics, The First Affiliated Hospital of Soochow University, People's Republic of China released this study marking the potential gentoxic/cytotoxic effects that cobalt might have on the patients T cells. In genetics, genotoxicity describes a deleterious action on a cell's genetic material affecting its integrity.
Cytotoxicity is the quality of being toxic to cells. T cells or T lymphocytes belong to a group of white blood cells known as lymphocytes, and play a central role in cell-mediated immunity. Lymphocytes identify invaders in the body and destroy them. In this case, we would be targeting cobalt as an invader in the body which the system would want to wipe out. If the T lymphocytes are not working properly and are inhibited, problems could arise of various sorts. The function of T cells and B cells is to recognize specific “non-self” antigens, during a process known as antigen presentation. Once they have identified an invader, the cells generate specific responses that are tailored to maximally eliminate specific pathogens or pathogen infected cells. B cells respond to pathogens by producing large quantities of antibodieswhich then neutralize foreign objects like bacteria and viruses. These tests were conduced in vitro. that is, they are lab experiments NOT conducted on humans or organisms.
Limited information is available on the potential risk of degradation products of metal-on-metal bearings in joint arthroplasty. The aim of this study was to investigate the cytotoxicity and genotoxicity of orthopedic-related cobalt nanoparticles on human T cells in vitro. T cells were collected using magnetic CD3 microbeads and exposed to different concentrations of cobalt nanoparticles and cobalt chloride. Cytotoxicity was evaluated by methyl thiazolyl tetrazolium and lactate dehydrogenase release assay. Cobalt nanoparticles dissolution in culture medium was determined by inductively coupled plasma-mass spectrometry. To study the probable mechanism of cobalt nanoparticles effects on T cells, superoxide dismutase, catalase, and glutathione peroxidase level was measured. Cobalt nanoparticles and cobalt ions could inhibit cell viability and enhance lactate dehydrogenase release in a concentration- and time-dependent manner (P < 0.05). The levels of cobalt ion released from cobalt nanoparticles in the culture medium were less than 40% and increased with cobalt nanoparticles concentration. Cobalt nanoparticles could induce primary DNA damage in a concentration-dependent manner, and the DNA damage caused by cobalt nanoparticles was heavier than that caused by cobalt ions. Cobalt nanoparticles exposure could significantly decrease superoxide dismutase, catalase, and glutathione peroxidase activities at subtoxic concentrations (6 μM, <CC(50)). These findings suggested that cobalt nanoparticles could generate potential risks to the T cells of patients suffer from metal-on-metal total hip arthroplasty, and the inhibition of antioxidant capacity may play important role in cobalt nanoparticles effects on T cells.




Imperial College London, Department of Musculoskeletal Surgery, London
Blood metal ions have been widely used to investigate metal-on-metal hip replacements, but their ability to discriminate between well-functioning and failed hips is not known. The Medicines and Healthcare products Regulatory Agency (MHRA) has suggested a cut-off level of 7 parts per billion (ppb). We performed a pair-matched, case-control study to investigate the sensitivity and specificity of blood metal ion levels for diagnosing failure in 176 patients with a unilateral metal-on-metal hip replacement. We recruited 88 cases with a pre-revision, unexplained failed hip and an equal number of matching controls with a well-functioning hip. We investigated the 7 ppb cut-off level for the maximum of cobalt or chromium and determined optimal mathematical cut-off levels from receiver-operating characteristic curves. The 7 ppb cut-off level for the maximum of cobalt or chromium had a specificity of 89% and sensitivity 52% for detecting a pre-operative unexplained failed metal on metal hip replacement. The optimal cut-off level for the maximum of cobalt or chromium was 4.97 ppb and had sensitivity 63% and specificity 86%. Blood metal ions had good discriminant ability to separate failed from well-functioning hip replacements. The MHRA cut-off level of 7 ppb provides a specific test but has poor sensitivity.

2 comments:

  1. Really very nice article. Everything has pros & cons. So if we use Cobalt nanoparticles carefully then it will not harm us.

    ReplyDelete
  2. you stupid fucking mental case get off this site!

    ReplyDelete